BGMS cyclacel.com Net earnings per share growth forecast for next year

Corporate company logo of Cyclacel (BGMS)

Can the reputation of Bio Green Med Solution Inc (BGMS) in precision oncology drive revenue growth? The EPS growth prospects for the next fiscal year provide the answer, where 0.00 captures the current value of the indicator. The business model relies on contract manufacturing and external clinical trials, while the company maintains a strong staff of translational medicine experts.

BGMS: Bio Green Med Solution Inc. Net earnings per one share growth forecast for next year 09/13/2025 - 11/15/2026

Financial and market metric breakdowns for Bio Green Med Solution (BGMS)

- share price and consensus valuation forecast:
Stock Price Cyclacel|BGMS - Analyst Consensus Forecast
- market capitalization data:
Market Value Cyclacel Pharmaceuticals|BGMS - Value Adjusted for Debt and Cash
- company book value details:
Book Value per Share Bio Green Med Solution|BGMS - Book Value of Business|Market Capitalization to Book Value Ratio cyclacel.com|BGMS - Company Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Bio Green Med Solution Inc|BGMS - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital cyclacel.com|BGMS - Company Cumulative Debt|Debts to Book Capitalization Cyclacel|BGMS - Company Long-Term Indebtedness|Company Current Liabilities Bio Green Med Solution|Quick Liquidity Indicator cyclacel.com
- earnings and valuation multiples information:
BGMS - Profit After Payment of Taxes|Projected Future Earnings Bio Green Med Solution Inc|BGMS - Company Value to Net Income|Forward P/E Multiple Cyclacel|BGMS - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cyclacel Pharmaceuticals|BGMS - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Bio Green Med Solution|BGMS - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months cyclacel.com|BGMS - Earnings per share trend in current year|Expected earnings per share growth for next year Bio Green Med Solution Inc
- sales and revenue data:
BGMS - Company Total Revenue|Projected Sales Volume Bio Green Med Solution Inc|BGMS - Price-to-Revenue Ratio|Forward P/S Multiple Cyclacel|BGMS - Annual Revenue Growth (Last Twelve Months)
Fundamental company analysis:Bio Green Med Solution, BGMS
Brand item of cyclacel.com

This indicator measures the expected percentage change in earnings per share, reflecting the analysts' consensus forecast regarding future business profitability. In the context of next year's earnings growth forecast, the ability of Bio Green Med Solution Inc. (BGMS) to raise capital to complete oncology research is critical given the current liquidity shortage. The trend of this metric determines the company's investment attractiveness amid the extreme operational risks of the biotech sector.

Competing companies

GMAB (Genmab Corp) - Earnings growth forecast for next year|Earnings growth forecast for next year exelixis.com|Net earnings per share growth forecast for next year Nuvalent (NUVL)|KYMR (Kymera) - Expected earnings per share trend next year|Earnings growth forecast for next year IDYA (IDEAYA Biosciences Inc)|Net earnings per one share growth forecast for next year Enliven Pharma|ORIC Pharmaceuticals Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year Relay Therapeutics, Inc.|NRIX (Nurix Therapeutics) - Expected earnings per share growth for next year|TYRA: Projected earnings per share increase next year|VSTM (verastem.com) - Earnings growth forecast for next year|Expected net earnings per share growth next year Monte Rosa Tx GLUE|Earnings growth forecast for next year CGEM|Immuneering - Projected earnings per share growth rate for next year|C4 Therapeutics - Expected earnings per share growth for next year|Expected earnings per share trend next year BDTX|RPTX: Expected earnings per share growth for next year|PMV Pharma - Projected earnings per share increase next year|KPTI: Earnings growth forecast for next year|Propanc Biopharma Inc. - Expected earnings per share trend next year|AADI (Aadi Bioscience Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year aileronrx.com ALRN|Net earnings per share growth forecast for next year Blueprint Medicines Corp. (BPMC)|GLYC (GlycoMimetics) - Expected earnings per share trend next year|Earnings growth forecast for next year SWTX (SpringWorks Therapeutics, Inc)